These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12225246)

  • 1. Therapeutic potential of GnRH antagonists in the treatment of precocious puberty.
    Roth C
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1253-9. PubMed ID: 12225246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists.
    Schultze-Mosgau A; Griesinger G; Altgassen C; von Otte S; Hornung D; Diedrich K
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1085-97. PubMed ID: 16144493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH antagonist cetrorelix prevents sexual maturation of peripubertal male rats.
    Roth C; Leonhardt S; Seidel C; Lakomek M; Wuttke W; Jarry H
    Exp Clin Endocrinol Diabetes; 2000; 108(5):358-63. PubMed ID: 10989955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Yen SS
    Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
    Sippell WG
    Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone and its analogs.
    Conn PM; Crowley WF
    Annu Rev Med; 1994; 45():391-405. PubMed ID: 8198390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty.
    Breyer P; Haider A; Pescovitz OH
    Clin Obstet Gynecol; 1993 Sep; 36(3):764-72. PubMed ID: 8403623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the etiology, diagnosis and treatment of central precocious puberty].
    Macedo DB; Cukier P; Mendonca BB; Latronico AC; Brito VN
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):108-17. PubMed ID: 24830587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of hypothalamic seizures and precocious puberty with GnRH analogue.
    Zaatreh M; Tennison M; Greenwood RS
    Neurology; 2000 Dec; 55(12):1908-10. PubMed ID: 11134395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone and its clinical applications.
    Loucopoulos A; Ferin M
    Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight: prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist: a proposed mechanism and management plan.
    Kauschansky A; Orvieto R; Yeshaya A; Shterntal B; Naor Z
    J Pediatr Adolesc Gynecol; 2011 Dec; 24(6):365-7. PubMed ID: 21872518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.